Pregabalin for the Prevention of Oxaliplatin‐Induced Painful Neuropathy: A Randomized, Double‐Blind Trial

LESSONS LEARNED. Pregabalin is a medication that can decrease neuronal hyperexcitability, relieve neuropathic pain, and reach stable plasma levels after a titration period of only a few days. Its use during oxaliplatin infusions was not able to decrease the incidence of chronic, oxalipaltin‐related...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: de Andrade, Daniel Ciampi, Jacobsen Teixeira, Manoel, Galhardoni, Ricardo, Ferreira, Karine S.L., Braz Mileno, Paula, Scisci, Nathalia, Zandonai, Alexandra, Teixeira, William G.J., Saragiotto, Daniel F., Silva, Valquíria, Raicher, Irina, Cury, Rubens Gisbert, Macarenco, Ricardo, Otto Heise, Carlos, Wilson Iervolino Brotto, Mario, Andrade de Mello, Alberto, Zini Megale, Marcelo, Henrique Curti Dourado, Luiz, Mendes Bahia, Luciana, Lilian Rodrigues, Antonia, Parravano, Daniella, Tizue Fukushima, Julia, Lefaucheur, Jean‐Pascal, Bouhassira, Didier, Sobroza, Evandro, Riechelmann, Rachel P., Hoff, Paulo M., Valério da Silva, Fernanda, Chile, Thais, Dale, Camila S., Nebuloni, Daniela, Senna, Luiz, Brentani, Helena, Pagano, Rosana L., de Souza, Ângela M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AlphaMed Press 2017
Soggetti:
Clinical Trial Results
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5634769/
https://ncbi.nlm.nih.gov/pubmed/28652279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0235
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi